Fig 1 (Figure 1)
Pregabalin Capsule
Product Images NDC 80425-0433
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig 10 (Figure 10)
This is a chart that displays the percentage of subjects without "LTR" (no indication of what LTR means). The percentages range from 0% to 100% in increments of 10%. The chart represents two groups, one called "Progabain" and the other "Placebo". The x-axis shows the number of days (ranging from 0 to 180) and the values associated with each percentage represent the estimated proportion of subjects without LTR within those days.*
Fig 11 (Figure 11)
Fig. 12 (Figure 12)
This appears to be a chart or graph showing the percent of subjects who improved from baseline to week 16 on a medication called pregabalin versus a placebo. The y-axis shows the percent of subjects improved, ranging from 0-100. The x-axis shows the range of numbers from 210 to 280. The chart shows that pregabalin had a higher percentage of subjects who improved compared to the placebo group at week 16.*
Fig 2 (Figure 2)
Fig 3 (Figure 3)
Fig 4 (Figure 4)
Fig 5 (Figure 5)
This text appears to be a medication dosage and efficacy chart for three drugs: Fregabalin 100 mg, Pregataiin 80 mg, and a Placebo. The chart displays the number of patients who improved after taking one of the three drugs. The results are represented numerically and graphically, showing a percentage improvement in pain from baseline for each drug.*
Fig 6 (Figure 6)
Fig 7 (Figure 7)
Fig 9 (Figure 9)
This is a chart that presents the percent of patients improved with a daily dose of Pregabalin (300mg and 450mg) compared to a placebo. The horizontal axis represents the baseline pain level, while the vertical axis represents the percent improvement in pain. There is no further information available for the evaluation.*
Label 1 (Pregabalin 50mg 80425 0327 01)
This is a description of a medication called Pregabalin. It comes in capsule form and there are 30 capsules per pack. The medication's lot number is 000000 and it expires on 4/20/2023. The product's source NDC is 50226-0351-90 and the NDC number is 80425-0327-01. There are additional characters/words on the document that do not form a coherent meaning.*
Label 2 (Pregabalin 50mg 80425 0327 02)
This is a description of a medicine called Pregabalin 50mg Capsule, which comes in a package of 60. It is noted to be comparable to another medication called Lyrica. The lot number is XKXXORRK and it is set to expire on April 20, 2023. There is also a serial number provided.*
Label 3 (Pregabalin 50mg 80425 0327 03)
This text appears to be a label for capsules of a medication called Pregabalin. The capsules come in a bottle with 90 capsules, similar to the medication Lyrica. The medication has a National Drug Code (NDC) of 50228-0351-90 and a lot number of XXX000KX that is set to expire on 4/20/2023. There is a symbol that reads "TR <~". There is not enough information to fully understand the purpose or usage of this medication.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
